130 related articles for article (PubMed ID: 38268429)
1. Improving the diagnosis of ductal carcinoma in situ with microinvasion without immunohistochemistry: An innovative method with H&E-stained and multiphoton microscopy images.
Han X; Liu Y; Zhang S; Li L; Zheng L; Qiu L; Chen J; Zhan Z; Wang S; Ma J; Kang D; Chen J
Int J Cancer; 2024 May; 154(10):1802-1813. PubMed ID: 38268429
[TBL] [Abstract][Full Text] [Related]
2. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
3. DCIS with Microinvasion: Is It In Situ or Invasive Disease?
Champion CD; Ren Y; Thomas SM; Fayanju OM; Rosenberger LH; Greenup RA; Menendez CS; Hwang ES; Plichta JK
Ann Surg Oncol; 2019 Oct; 26(10):3124-3132. PubMed ID: 31342393
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?
Klauber-DeMore N; Tan LK; Liberman L; Kaptain S; Fey J; Borgen P; Heerdt A; Montgomery L; Paglia M; Petrek JA; Cody HS; Van Zee KJ
Ann Surg Oncol; 2000 Oct; 7(9):636-42. PubMed ID: 11034239
[TBL] [Abstract][Full Text] [Related]
5. Clinical and imaging characteristics of breast ductal carcinoma in situ with microinvasion.
Han S; Qiu F; Han Y; Xu Y; Yin J; Xing F; Bian X; He G
J Appl Clin Med Phys; 2021 Jan; 22(1):293-298. PubMed ID: 33332730
[TBL] [Abstract][Full Text] [Related]
6. Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation.
Parikh RR; Haffty BG; Lannin D; Moran MS
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):7-13. PubMed ID: 20950955
[TBL] [Abstract][Full Text] [Related]
7. Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis.
Zhang G; Li C; Tian G; Cheng X; Li Y; Ma L
Medicine (Baltimore); 2020 Dec; 99(52):e23593. PubMed ID: 33350734
[TBL] [Abstract][Full Text] [Related]
8. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A
Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797
[TBL] [Abstract][Full Text] [Related]
9. The clinical features and management of women with ductal carcinoma in situ with microinvasion: A retrospective Cohort study.
Li Y; Zhang S; Wei X; Zhang J
Int J Surg; 2015 Jul; 19():91-4. PubMed ID: 26013173
[TBL] [Abstract][Full Text] [Related]
10. Is Sentinel Lymph Node Biopsy Required for a Core Biopsy Diagnosis of Ductal Carcinoma In Situ with Microinvasion?
Flanagan MR; Stempel M; Brogi E; Morrow M; Cody HS
Ann Surg Oncol; 2019 Sep; 26(9):2738-2746. PubMed ID: 31147995
[TBL] [Abstract][Full Text] [Related]
11. Axillary staging in ductal carcinoma in situ with microinvasion: A meta-analysis.
Choi B; Jegatheeswaran L; Nakhoul M; Haria P; Srivastava R; Karki S; Lupi M; Patel V; Chakravorty A; Babu E
Surg Oncol; 2021 Jun; 37():101557. PubMed ID: 33819852
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of breast ductal carcinoma in situ with microinvasion: a narrative review.
Zheng J; Yu J; Zhou T
J Int Med Res; 2020 Nov; 48(11):300060520969304. PubMed ID: 33179556
[TBL] [Abstract][Full Text] [Related]
13. [The value of immunohistochemical expression of Ki-67 and CD34 in differentiating ductal carcinoma in situ from ductal carcinoma in situ-like invasive breast cancer].
Pan XY; Wu JK; Lang ZQ; Qu L; Jiang L
Zhonghua Bing Li Xue Za Zhi; 2022 Sep; 51(9):838-842. PubMed ID: 36097899
[No Abstract] [Full Text] [Related]
14. Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases.
Yang M; Moriya T; Oguma M; De La Cruz C; Endoh M; Ishida T; Hirakawa H; Orita Y; Ohuchi N; Sasano H
Pathol Int; 2003 Jul; 53(7):422-8. PubMed ID: 12828606
[TBL] [Abstract][Full Text] [Related]
15. Visualization of lymphatic vascular invasion in breast cancer by multiphoton microscopy.
Ren W; Guo W; Kang D; Han Z; He J; Xi G; Wang C; Chen J; Li L
Lasers Med Sci; 2021 Mar; 36(2):303-309. PubMed ID: 32681221
[TBL] [Abstract][Full Text] [Related]
16. Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma.
Hua X; Yu L; Huang X; Liao Z; Xian Q
Diagn Pathol; 2011 Nov; 6():111. PubMed ID: 22067528
[TBL] [Abstract][Full Text] [Related]
17. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
Wilkie C; White L; Dupont E; Cantor A; Cox CE
Am J Surg; 2005 Oct; 190(4):563-6. PubMed ID: 16164920
[TBL] [Abstract][Full Text] [Related]
18. Label-Free Identification of Early Stages of Breast Ductal Carcinoma via Multiphoton Microscopy.
Chen Z; Guo W; Kang D; Wang S; Zheng L; Xi G; Lian Y; Wang C; Chen J
Scanning; 2020; 2020():9670514. PubMed ID: 32454928
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida.
Camp R; Feezor R; Kasraeian A; Cendan J; Schell S; Wilkinson E; Copeland E; Lind S
Breast J; 2005; 11(6):394-7. PubMed ID: 16297082
[TBL] [Abstract][Full Text] [Related]
20. An MRI-Based Radiomics Nomogram to Distinguish Ductal Carcinoma In Situ with Microinvasion From Ductal Carcinoma In Situ of Breast Cancer.
Wu Z; Lin Q; Wang H; Wang G; Fu G; Bian T
Acad Radiol; 2023 Sep; 30 Suppl 2():S71-S81. PubMed ID: 37211478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
